Approval · Notice of Compliance 4597 · 1996
ZOFRAN: Notice of Compliance 4597
Issued September 26, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4597
- Date
- September 26, 1996
- Company
- Glaxo Canada IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New dosage form
- Therapeutic class
- Antiemetic (5-ht3 receptor antagonist)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZOFRAN | 02229639 | Cancelled Post Market |
Medicinal ingredients
- ONDANSETRON HCL 4 MG per 5ML